CLINICAL_TRIALS
trial_result
· 2014-08-12
Clinical Trial Update: Rituximab and GM-CSF in Treating Patients With Chronic Lymphocytic Leukemia [Phase 2]
Summary
Phase 2 trial evaluating rituximab in combination with GM-CSF for chronic lymphocytic leukemia; the study is terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Leukemia | Phase 2 | Status: TERMINATED